Citation: | LIU Zhong-cheng, DONG Xin-shu, WANG Dong-hua. Expression Of P21, P53 In Rectal Cancer And Clinical Significance[J]. Cancer Research on Prevention and Treatment, 1999, 26(4): 281-283. |
[1] |
船桥公彦.大肠癌にすけるras 癌遗佾子产物の现に阌する研究.日本大肠肛病仝论志, 1993, 46(1): 1-9;
|
[2] |
石岛直人.大肠癌腺肿の生、进展とRas Oncogene P21现に阌する免疫组织化学的研究.日本大肠肛门病会, 1990, 43(4): 554;
|
[3] |
Bernhard , SUCHY, K-Ras.Point mutations in human colorectal car cinomas recation to aneaploiclg and me tastas is Int J. Cancer, 1990, 52: 30;
|
[4] |
桥公彦.Ras 癌遗会子产物力的见太大肠癌检讨.大肠肛门病会志, 1991, 44(2): 160;
|
[5] |
小出章.大肠腺肿, 癌にすけるP53核蛋白の免疫组织学的研究.日本大肠肛门病仝志, 1993, 46(1):20;
|
[6] |
岩本亚.大肠癌にすけP53异常蛋白出现の临床的意义.日癌疗志, 1992, 27(8): 26;
|
[7] |
钱木华.人大肠肿瘤组织P53基因突变表达及临床意义.中华肿瘤杂志, 1995, 17(5): 332;
|
[8] |
ReinVIKos .Y.Increased P53 protein content of colorectal tumours correlats.wieh poor Survival.Br .J. Carcer, 1992, 66: 758.
|